Obesity and hepatic steatosis are known to strongly induce SCD1 expression, whereas rodents that are specifically deficient in SCD1 in the liver are protected from developing hepatic steatosis by reducing lipid synthesis and increasing FFA β-oxidation and insulin sensitivity (38). This evidence concerns the gene INS and obesity disorder.